Vanguard Fiduciary Trust
ATYR

Vanguard Fiduciary Trust’s aTyr Pharma ATYR Stock Holding History

Vanguard Fiduciary Trust’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$344K Sell
576,125
-75,707
-12% -$49.5K ﹤0.01% 3401
2026
Q1 		$508K Buy
+651,832
New +$550K ﹤0.01% 3207

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $140M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Fiduciary Trust's ATYR Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its aTyr Pharma (ATYR) stake by 12% in Q2 2026, selling an estimated $49.5K and leaving 576,125 shares worth $344K. The position accounts for ﹤0.01% of the portfolio, ranked #3401.

Vanguard Fiduciary Trust first reported a position in ATYR in Q1 2026 and has held it in 2 quarters since. The position peaked at $508K in Q1 2026. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Vanguard Fiduciary Trust held 576,125 shares of aTyr Pharma worth $344K as of Q2 2026.
  • Vanguard Fiduciary Trust sold 75,707 aTyr Pharma shares in Q2 2026, an estimated $49.5K.
  • aTyr Pharma made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3401 holding.
  • Vanguard Fiduciary Trust first reported a position in aTyr Pharma in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's aTyr Pharma position peaked at $508K in Q1 2026.
  • 90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.